News

Cephalosporin Drugs Market Growth Rate Analysis 2019 Intelligence Insights of Market Size, Scope, Breakdown Data Forecast to 2024

Cephalosporin Drugs

Report Titled: “Cephalosporin Drugs Market – Growth, Trends, and Forecast (2019 – 2024)

The Cephalosporin Drugs Market report 2019 provides complete information of key players across the globe. Company provides detailed analysis of market and future aspects of “Cephalosporin Drugs Market”. The report focuses on critical and significant data which makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis.

Scope of the Report:

  • As per the scope of this report, cephalosporins are part of the beta-lactams group and work by interfering with the synthesis of the bacterial cell wall. Some may be given orally, but most are given by injection. They are typically the second choice antibiotic, their main uses are in pneumonia, septicemia, meningitis, sinusitis, and UTIs treatment. Despite their second-line usage, cephalosporins have a broader spectrum of activity and are more potent than penicillin.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245334

    Market Overview:

  • – The major factors for the growth of the cephalosporin drugs market include the rising demand for anti-microbial in various indications, rising prevalence of infectious diseases, and increasing use of combination therapies.
  • – Most of the small companies out-license the products after taking them through the early clinical development phase. These agreements usually include one-time payment for obtaining the rights, in addition to the milestone payments on completing designated developmental phase and royalties on sales. There are over 50 cephalosporin drugs that have been approved in the past five decades, and almost half of them are for the antibacterial activity. However, new cephalosporins (classified as the fifth-generation), which are used for the treatment of serious gram-negative bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA), were recently approved.
  • – Manufacturers are involved in the development of new drugs to fight against anti-microbial resistance. The complexity and diversity of resistance mechanisms have defined the need for new and improved β-lactam antibiotics. Additionally, the companies are involved in the strategic development of new products, for example, in 2017, Shionogi & Co. Ltd collaborated with the F. Hoffmann-La Roche Ltd for the development and commercialization of baloxavir marboxi.
  • – Thus, owing to the all above-mentioned factors the cephalosporin drugs market is expected to witness high growth over the forecast per

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Cephalosporin Drugs Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Cephalosporin Drugs .

    Enquire Before Purchasing this Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245334

    Key Market Trends:

    The Fifth-generation Segment is Expected to Account for the Largest Market Share During the Forecast Period

    The fifth-generation cephalosporins were developed in the lab to specifically target resistant strains of bacteria. In particular, ceftobiprole is effective against methicillin-resistant staphylococcus aureus (MRSA). These agents are sometimes referred to as the advanced generation, rather than fifth-generation cephalosporins. Cephalosporins exhibit side effects similar to penicillin, and drug-allergy and hypersensitivity. Cephalosporins, in general, have been associated with little hepatotoxicity and rare instances of drug-induced liver injury. The fifth-generation cephalosporins include Ceftobiprole, Ceftaroline, and Ceftolozane. Ceftobiprole has powerful antipseudomonal characteristics and appears to be less susceptible to the development of resistance. Ceftaroline has also been described as the “fifth-generation” cephalosporin, but does not have the antipseudomonal or VRE coverage of ceftobiprole. The market for Ceftolozane is growing at a good pace, as it has opened gates for an alternative for the treatment of complicated intra-abdominal infections (CIAI) and complicated urinary tract infections (CUTI). Furthermore, Ceftolozane is combined with the β-lactamase inhibitor tazobactam, as multi-drug resistant bacterial infections generally exhibit resistance to all β-lactam antibiotics, unless this enzyme is inhibited. Hence, the increase in the use of combination therapies is expected to drive the market during the forecast period.

    Asia-Pacific is Expected to be the Fastest Growing Segment in the Global Market

    Asia-Pacific is expected to dominate this market, due to the high prevalence of infectious diseases, increasing healthcare expenditure, and a large population base. Furthermore, the demand for better healthcare infrastructure and government initiatives is expected to help the growth of the market in this region. As per the statistics published by the World Health Organization (WHO) TB statistics for India for 2016, an estimated incidence of tuberculosis (TB) is 2.79 million cases in India. Thus, rising cases of various infections are expected to boost the overall growth of the market. Asia-Pacific is followed by Europe, due to its large base of geriatric population and rising prevalence of infectious diseases in several countries of the region.

    For Detailed TOC, Click Here: https://www.industryresearch.co/TOC/14245334#TOC

    Cephalosporin Drugs Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:

  • Aristo Pharmaceuticals Ltd
  • Baxter International
  • F. Hoffmann
  • La Roche AG
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd
  • Mankind Pharma
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd

    What Cephalosporin Drugs Market Report Provides:

    • Value chain analysis
    • Ecosystem analysis
    • Key players in ecosystem
    • Report highlights top manufacturers/suppliers/providers
    • Analysis of portfolio
    • Key distributors

    Some Major Points Covered in Cephalosporin Drugs Market Report:

    • Introduction and Market Overview
    • Industry Chain Analysis
    • Market, by Type
    • Market, by Application
    • Production, Value ($) by Region (2014-2019)
    • Production, Consumption, Export, Import by Regions (2014-2019)
    • Market Status and SWOT Analysis by Regions
    • Competitive Landscape
    • Analysis and Forecast by Type and Application
    • Analysis and Forecast by Region
    • New Project Feasibility Analysis
    • Research Finding and Conclusion

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245334

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    MRI Systems Market 2019 Global Industry Trends by Market Size, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2024

    Diesel Generators Market Growth and Share Analysis by Leading Countries, Top Key Players, Regions, Forecast to 2019-2025

    Sustainable Paper Market 2019-2025 | Report includes Industrial potential Growth with Market share analysis and also include Key Players, Industry Challenges, Key Vendors, Drivers, Trends

  • Related Articles

    Close